New Issue: UBS prices $149,971 8.71% trigger yield optimization notes on SPDR S&P Biotech

New York, Sept. 10 – UBS AG, London Branch priced $149,971.85 of 8.71% trigger yield optimization notes due Sept. 15, 2021 linked to the shares of SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The face amount of each note is $104.51, which is equal to the initial share price of the ETF.

Interest is payable monthly.

The payout at maturity will be par unless the final price of the ETF is less than 80% of the initial share price, in which case investors will receive one ETF share per note.

UBS Financial Services Inc. and UBS Investment Bank are the underwriters.

Issuer:	UBS AG, London Branch
Issue:	Trigger yield optimization notes
Underlying ETF:	SPDR S&P Biotech ETF
Amount:	$149,971.85
Maturity:	Sept. 15, 2021
Coupon:	8.71%, payable monthly
Price:	Par of $104.51
Payout at maturity:	If final share price is less than trigger price, one share; otherwise, par
Initial share price:	$104.51
Trigger price:	$83.61, 80% of initial price
Pricing date:	Sept. 10
Settlement date:	Sept. 14
Underwriters:	UBS Financial Services Inc. and UBS Investment Bank
Fees:	1.53%
Cusip:	90281U690

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.